x
Filter:
Filters applied
- Clinical Practice Guidelines and Recommendations
- Kopecky, Stephen LRemove Kopecky, Stephen L filter
- LDL-CRemove LDL-C filter
Author
- Lopez-Jimenez, Francisco3
- Allison, Thomas G2
- Hurst, R Todd2
- Kullo, Iftikhar J2
- Mulvagh, Sharon L2
- Thomas, Randal J2
- Trejo-Gutierrez, Jorge F2
- Arruda-Olson, Adelaide M1
- Basu, Ananda1
- Blaha, Michael J1
- Blumenthal, Roger S1
- Cainzos-Achirica, Miguel1
- Desai, Chintan S1
- Fernandes, Regis1
- Hayes, Sharonne N1
- Martin, Seth S1
- Pollak, Amy W1
- Simha, Vinaya1
- Thompson, Warren G1
- Wang, Libin1
- Wright, R Scott1
Keyword
- Adult Treatment Panel III3
- ASCVD3
- atherosclerotic cardiovascular disease3
- CHD3
- coronary heart disease3
- ABI2
- ACC/AHA2
- American College of Cardiology/American Heart Association2
- ATP III2
- CAC2
- coronary artery calcium2
- CVD2
- 4S1
- A to Z1
- ACC1
- ACCORD1
- Action to Control Cardiovascular Risk in Diabetes1
- AFCAPS-TexCAPS1
- Aggrastat to Zocor1
- AHA1
- ALT1
- ASCOT-LLA1
- ASPEN1
- ATP-III1
Clinical Practice Guidelines and Recommendations
3 Results
- Review
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines
Mayo Clinic ProceedingsVol. 90Issue 9p1262–1271Published online: August 11, 2015- Miguel Cainzos-Achirica
- Chintan S. Desai
- Libin Wang
- Michael J. Blaha
- Francisco Lopez-Jimenez
- Stephen L. Kopecky
- and others
Cited in Scopus: 16The 2013 American College of Cardiology/American Heart Association cardiovascular disease prevention guidelines represent an important step forward in the risk assessment and management of atherosclerotic cardiovascular disease in clinical practice. Differentiated risk prediction equations for women and black individuals were developed, and convenient 10-year and lifetime risk assessment tools were provided, facilitating their implementation. Lifestyle modification was portrayed as the foundation of preventive therapy. - Special article
A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
Mayo Clinic ProceedingsVol. 89Issue 9p1257–1278Published online: August 13, 2014- Francisco Lopez-Jimenez
- Vinaya Simha
- Randal J. Thomas
- Thomas G. Allison
- Ananda Basu
- Regis Fernandes
- and others
Cited in Scopus: 36The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has recently released the new cholesterol treatment guideline. This update was based on a systematic review of the evidence and replaces the previous guidelines from 2002 that were widely accepted and implemented in clinical practice. The new cholesterol treatment guideline emphasizes matching the intensity of statin treatment to the level of atherosclerotic cardiovascular disease (ASCVD) risk and replaces the old paradigm of pursuing low-density lipoprotein cholesterol targets. - Special article
A Perspective on the New American College of Cardiology/American Heart Association Guidelines for Cardiovascular Risk Assessment
Mayo Clinic ProceedingsVol. 89Issue 9p1244–1256Published online: August 13, 2014- Iftikhar J. Kullo
- Jorge F. Trejo-Gutierrez
- Francisco Lopez-Jimenez
- Randal J. Thomas
- Thomas G. Allison
- Sharon L. Mulvagh
- and others
Cited in Scopus: 18The recently published American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cardiovascular risk assessment provide equations to estimate the 10-year and lifetime atherosclerotic cardiovascular disease (ASCVD) risk in African Americans and non-Hispanic whites, include stroke as an adverse cardiovascular outcome, and emphasize shared decision making. The guidelines provide a valuable framework that can be adapted on the basis of clinical judgment and individual/institutional expertise.